Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
Ali Rezaie, Zeev Heimanson, Richard W. McCallum, et al.
The American Journal of Gastroenterology (2019) Vol. 114, Iss. 12, pp. 1886-1893
Open Access | Times Cited: 68

Showing 26-50 of 68 citing articles:

Pros and Cons of Breath Testing for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth.
Jane Lim, Ali Rezaie
PubMed (2023) Vol. 19, Iss. 3, pp. 140-146
Closed Access | Times Cited: 9
Small intestinal bacterial overgrowth in patients with inflammatory bowel disease: A case-control study
Uday C. Ghoshal, Ankur Yadav, Bushra Fatima, et al.
Indian Journal of Gastroenterology (2021) Vol. 41, Iss. 1, pp. 96-103
Closed Access | Times Cited: 18
Update on the Role of Rifaximin in Digestive Diseases
Dan L. Dumitrașcu, И. Г. Бакулин, Annalisa Berzigotti, et al.
Journal of Gastrointestinal and Liver Diseases (2023) Vol. 32, Iss. 1, pp. 92-109
Open Access | Times Cited: 7
Small Intestinal Bacterial Overgrowth In Various Functional Gastrointestinal Disorders: A Case–Control Study
Kee Huat Chuah, Mung Seong Wong, Phei Oon Tan, et al.
Digestive Diseases and Sciences (2021) Vol. 67, Iss. 8, pp. 3881-3889
Closed Access | Times Cited: 16
Review article: Diagnosis and investigation of irritable bowel syndrome
Christopher J. Black
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. S1
Open Access | Times Cited: 14
Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study)
Huaizhu Guo, Siqi Lu, Jindong Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Recent advances in diagnosis and management of irritable bowel syndrome
Karen Van den Houte, Esther Colomier, Jolien Schol, et al.
Current Opinion in Psychiatry (2020) Vol. 33, Iss. 5, pp. 460-466
Closed Access | Times Cited: 13
Campylobacter infection and the link with Irritable Bowel Syndrome:on the pathway towards a causal association
Will Takakura, Praneeth Kudaravalli, Chandrima Chatterjee, et al.
Pathogens and Disease (2022) Vol. 80, Iss. 1
Closed Access | Times Cited: 9
Small Intestinal Bacterial Overgrowth Breath Testing in Gastroenterology: Clinical Utility and Pitfalls
Vikram Rangan, Judy Nee, Anthony Lembo
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 7, pp. 1450-1453
Open Access | Times Cited: 9
Journal of Clinical Gastroenterology Lectureship Dubai 2022
Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Journal of Clinical Gastroenterology (2024) Vol. 58, Iss. 3, pp. 221-231
Open Access | Times Cited: 1
Bakterielle Fehlbesiedlung des Dünndarms
Gernot Sellge
Aktuelle Ernährungsmedizin (2024) Vol. 49, Iss. 02, pp. 156-172
Closed Access | Times Cited: 1
Common questions and rationale answers about the intestinal bacterial overgrowth syndrome (SIBO)
Javier Alcedo González, Fermín Estremera, Julyssa Cobián Malaver, et al.
Gastroenterología y Hepatología (English Edition) (2024), pp. 502216-502216
Closed Access | Times Cited: 1
Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome
Joost P. Algera, Hans Törnblom, Magnus Simrén
Current Opinion in Pharmacology (2022) Vol. 66, pp. 102284-102284
Open Access | Times Cited: 6
The spectrum of gastrointestinal functional bowel disorders in joint hypermobility syndrome and in an academic referral center
Priyadarshini Loganathan, Daniel Herlihy, Mahesh Gajendran, et al.
Journal of Investigative Medicine (2023) Vol. 72, Iss. 1, pp. 162-168
Closed Access | Times Cited: 3
Small intestinal bacterial overgrowth in inflammatory bowel disease
Ayesha Shah, Gerald Holtmann
Indian Journal of Gastroenterology (2022) Vol. 41, Iss. 1, pp. 23-29
Closed Access | Times Cited: 5
Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity
Zuojing Liu, Shiwei Zhu, Meibo He, et al.
Chinese Medical Journal (2022) Vol. 135, Iss. 14, pp. 1716-1727
Open Access | Times Cited: 5
Targeted pharmacotherapy of irritable bowel syndrome
Abishek Arokiadoss, H. Christian Weber
Current Opinion in Endocrinology Diabetes and Obesity (2021) Vol. 28, Iss. 2, pp. 214-221
Closed Access | Times Cited: 6
Use of Lactulose Breath Tests to Predict Response to Rifaximin in Irritable Bowel Syndrome With Diarrhea: The Positives and Negatives
Christopher J. Black, Alexander C. Ford
The American Journal of Gastroenterology (2020) Vol. 115, Iss. 6, pp. 955-956
Closed Access | Times Cited: 4
Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review
Cristina Iribarren, Lujain Maasfeh, Lena Öhman, et al.
Gut Microbiome (2022) Vol. 3
Open Access | Times Cited: 3
Primer consenso centroamericano y del Caribe del síndrome de intestino irritable
Jorge Antonio Galdámez Estrada, Luis Aguilar Paiz, Gianna Minerva Blanco, et al.
Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana (2023) Vol. 53, Iss. 2, pp. 137-163
Open Access | Times Cited: 1
Effects of a Nutraceutical Multicompound, with Probiotics, Hericium, PEA, and Undaria in Patients with Irritable Bowel Syndrome
António Romano, Linda Balestrini, Giulia Della Scala, et al.
Journal of Dietary Supplements (2024) Vol. 21, Iss. 4, pp. 451-461
Closed Access
Alcohol use disorder. The other disease.
MJ Lobo Lara, Alfredo Gea, MA Martínez
Revista Andaluza de Patología Digestiva (2024) Vol. 47, Iss. 1, pp. 30-36
Open Access
Gastrostomy tube dislodgement into the peritoneal cavity after its manual insertion
A Torres Domínguez, Santiago Peralta, R. Rivera Irigoín
Revista Andaluza de Patología Digestiva (2024) Vol. 47, Iss. 1, pp. 43-44
Open Access
Urinary ascites after transurethral resection in a cirrhotic patient
R Fernández García, R Lecuona Muñoz, Patricia Abellán Alfocea, et al.
Revista Andaluza de Patología Digestiva (2024) Vol. 47, Iss. 1, pp. 40-42
Open Access
Intestinal overgrowth. Are we on the right track?
JM Pérez Pozo
Revista Andaluza de Patología Digestiva (2024) Vol. 47, Iss. 1, pp. 21-29
Open Access

Scroll to top